BCAB
BioAtla, Inc. Common Stock
$0.82
-3.30%
-0.03
Notify me if price changes either direction
Buy BCAB stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
48.5M
Enterprise value
49.0M
Trailing PE
-0.68727148460314
Forward PE
-0.5912925
PEG Ratio
-0.030239945322538
Enterprise to EBITDA
-0.752
Enterprise to revenue
4.4511894545455
Price to book MRQ
-1.5522747321981
Price to sales TTM
4.4115443636364
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
11.0M
EBITDA
-65112000
Diluted EPS TTM
-1.15
Total Cash (MRQ)
8.3M
Current ratio (MRQ)
0.538
Operating Cash Flow (TTM)
-57072000
BCAB trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
November 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
